When clinical psychiatrist and University of Queensland researcher Dr Cathy Franklin saw her first patient with Catatonia and Acute Regression in Down Syndrome in 2009, she was shocked. The condition ...
CHLA launches first clinical trial for Down syndrome regression disorder with $5.3 million NIH grant
Children's Hospital Los Angeles has launched the first clinical trial for Down syndrome regression disorder (DSRD), a rare and debilitating condition that affects adolescents and young adults with ...
Researchers led by CHLA’s Jonathan D. Santoro, MD, have identified signs of neuroinflammation and dysfunction of the blood-brain barrier among patients with Down syndrome Regression Disorder (DSRD). A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results